TOFANTA 5

About

TOFANTA 5 contains Tofacitinib, an oral Janus kinase (JAK) inhibitor used to treat various autoimmune and inflammatory conditions. It works by blocking the activity of JAK enzymes, which are intracellular signaling molecules crucial for the signaling pathways of cytokines and growth factors involved in immune responses and inflammation. By inhibiting these pathways, Tofacitinib effectively reduces the inflammatory processes that drive diseases like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

This targeted therapy offers an alternative to traditional immunosuppressants and biologics, providing significant relief from symptoms such as joint pain, swelling, and stiffness, and helping to prevent disease progression. Due to its mechanism of action, it requires careful patient selection and monitoring for potential side effects, including infections and cardiovascular risks.

Uses

• Treatment of moderate to severe rheumatoid arthritis
• Management of active psoriatic arthritis
• Treatment of moderate to severe ulcerative colitis
• Management of active ankylosing spondylitis

Directions For Use

Take exactly as prescribed by your physician, usually once or twice daily, with or without food. Do not crush, cut, or chew the tablet.

Benefits

• Significantly reduces joint pain and swelling
• Improves physical function and mobility
• Slows the progression of joint damage
• Effective in moderate to severe autoimmune conditions
• Offers oral administration convenience
• Reduces systemic inflammation markers

Side Effects

• Increased risk of infections (e.g., upper respiratory, herpes zoster)
• Headache
• Diarrhea
• Nausea
• Elevated cholesterol levels
• Elevated liver enzymes
• Anemia
• Neutropenia (low white blood cell count)
• Hypertension (high blood pressure)
• Deep vein thrombosis (DVT)
• Pulmonary embolism (PE)
• Increased risk of malignancy (lymphoma, skin cancer)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase the risk of liver toxicity and other side effects, and may exacerbate gastrointestinal issues.
• Pregnancy - Contraindicated during pregnancy as it can cause fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Not recommended during breastfeeding as tofacitinib passes into breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution in patients with liver conditions. Dose adjustment may be required in moderate to severe hepatic impairment; monitor liver function closely.
• Kidney - Use with caution in patients with kidney conditions. Dose adjustment may be required in moderate to severe renal impairment; monitor kidney function closely.
• Lung - Increased risk of serious infections, including opportunistic infections like tuberculosis and other lung infections. Screen for TB before starting treatment.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.